EAPIF
Price
$3.09
Change
-$0.56 (-15.34%)
Updated
Aug 6 closing price
Capitalization
327.62M
SHPH
Price
$4.01
Change
-$0.13 (-3.14%)
Updated
Sep 26 closing price
Capitalization
4.29M
Interact to see
Advertisement

EAPIF vs SHPH

Header iconEAPIF vs SHPH Comparison
Open Charts EAPIF vs SHPHBanner chart's image
EUROAPI SA
Price$3.09
Change-$0.56 (-15.34%)
Volume$292
Capitalization327.62M
Shuttle Pharmaceuticals Holdings
Price$4.01
Change-$0.13 (-3.14%)
Volume$74.05K
Capitalization4.29M
EAPIF vs SHPH Comparison Chart in %
Loading...
EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EAPIF vs. SHPH commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EAPIF is a Hold and SHPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (EAPIF: $3.09 vs. SHPH: $4.01)
Brand notoriety: EAPIF and SHPH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: EAPIF: 35% vs. SHPH: 125%
Market capitalization -- EAPIF: $327.62M vs. SHPH: $4.29M
EAPIF [@Pharmaceuticals: Generic] is valued at $327.62M. SHPH’s [@Pharmaceuticals: Generic] market capitalization is $4.29M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EAPIF’s FA Score shows that 0 FA rating(s) are green whileSHPH’s FA Score has 0 green FA rating(s).

  • EAPIF’s FA Score: 0 green, 5 red.
  • SHPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both EAPIF and SHPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EAPIF’s TA Score shows that 2 TA indicator(s) are bullish while SHPH’s TA Score has 6 bullish TA indicator(s).

  • EAPIF’s TA Score: 2 bullish, 1 bearish.
  • SHPH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SHPH is a better buy in the short-term than EAPIF.

Price Growth

EAPIF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while SHPH (@Pharmaceuticals: Generic) price change was -1.96% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EAPIF($328M) has a higher market cap than SHPH($4.29M). EAPIF YTD gains are higher at: 2.890 vs. SHPH (-81.327). SHPH has higher annual earnings (EBITDA): -11.67M vs. EAPIF (-37.9M). EAPIF has more cash in the bank: 57.8M vs. SHPH (4.82M). SHPH has less debt than EAPIF: SHPH (713K) vs EAPIF (68.4M). EAPIF has higher revenues than SHPH: EAPIF (883M) vs SHPH (0).
EAPIFSHPHEAPIF / SHPH
Capitalization328M4.29M7,639%
EBITDA-37.9M-11.67M325%
Gain YTD2.890-81.327-4%
P/E Ratio7.92N/A-
Revenue883M0-
Total Cash57.8M4.82M1,200%
Total Debt68.4M713K9,593%
TECHNICAL ANALYSIS
Technical Analysis
EAPIFSHPH
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 7 days ago
45%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
38%
Bullish Trend 5 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
35%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
32%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
47%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TQAIX47.240.55
+1.18%
T. Rowe Price Integrated US Sm Gr Eq I
AXVIX19.130.21
+1.11%
Acclivity Small Cap Value I
BWLIX25.840.28
+1.10%
American Beacon Man Lg Cp Value Inv
MRCGX29.650.30
+1.02%
Meridian Growth C
IBNYX25.840.05
+0.19%
Macquarie Balanced Fund Class Y

EAPIF and

Correlation & Price change

A.I.dvisor tells us that EAPIF and ALVO have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAPIF and ALVO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
ALVO - EAPIF
23%
Poorly correlated
+2.71%
AKAN - EAPIF
19%
Poorly correlated
+2.37%
PLSH - EAPIF
6%
Poorly correlated
-13.64%
STEK - EAPIF
5%
Poorly correlated
+18.32%
SHPH - EAPIF
1%
Poorly correlated
-3.26%
More

SHPH and

Correlation & Price change

A.I.dvisor tells us that SHPH and LFCR have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPH and LFCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPH
1D Price
Change %
SHPH100%
-3.26%
LFCR - SHPH
31%
Poorly correlated
+2.94%
PLSH - SHPH
24%
Poorly correlated
-13.64%
IPSEF - SHPH
20%
Poorly correlated
N/A
LIEN - SHPH
20%
Poorly correlated
+0.50%
BFRI - SHPH
11%
Poorly correlated
-0.02%
More